未登录 分享 收藏
分享 收藏
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer PD-1阻断联合化疗在致癌基因驱动的非小细胞肺癌患者中的疗效 Wang, Haowei; Cheng, Lei; Chen, Jian; Chen, Peixin; Tang, Zhuoran; Wang, Qianyi; Ma, Ying; Zhao, Chao; Li, Xuefei; Jiang, Tao; Zhou, Fei; Chen, Xiaoxia; Zhou, Caicun 分享 收藏
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations 紫杉醇治疗药物监测——国际治疗药物监测与临床毒理学协会建议 Hertz, Daniel L.; Joerger, Markus; Bang, Yung-Jue; Mathijssen, Ron H.; Zhou, Caicun; Zhang, Li; Gandara, David; Stahl, Michael; Monk, Bradley J.; Jaehde, Ulrich; Beumer, Jan H. 分享 收藏
Phase I dose escalation of ASKC202, a novel cMET tyrosine kinase inhibitor, in patients with advanced solid tumors Song, Tingting; Zhou, Caicun; Li, Wei; Li, Xingya; Wu, Lin; Zeng, Shan; Miao, Liyun; Liu, Baogang; Wei, Xuyu; Chen, Jing; Han, Luwei 分享 收藏
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC 一线Selpercatinib或化疗和Pembrolizumab治疗RET融合阳性NSCLC Zhou, Caicun; Solomon, Benjamin; Loong, Herbert H.; Park, Keunchil; Perol, Maurice; Arriola, Edurne; Novello, Silvia; Han, Baohui; Zhou, Jianying; Ardizzoni, Andrea; Mak, M. Perez; Santini, Fernando C.; Elamin, Yasir Y.; Drilon, Alexander; Wolf, Juergen; Payakachat, Nalin; Uh, Minji K.; Rajakumar, Deborah; Han, Hongmei; Puri, Tarun; Soldatenkova, Victoria; Lin, A. Bence; Lin, Boris K.; Goto, Koichi 分享 收藏
Treatment patterns and clinical outcomes of patients with unresectable advanced or metastatic (UAM) gastric/gastroesophageal junction adenocarcinoma (GA/GEJA) in China: A multicenter real-world study Zhang, Y.; Zhang, J.; Xie, X.; Pan, W.; Wang, G.; Dong, Q.; Zhang, N.; Dong, J.; Segall, G.; Zhou, L.; Zhou, C.; Khanal, M.; Yang, Y.; Zeng, L. 分享 收藏
Amivantamab plus chemotherapy vs chemotherapy as firstline treatment in EGFR Exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): Primary results from PAPILLON, a randomized phase III global study Girard, N.; Park, K.; Tang, K.; Cho, B. C.; Paz-Ares, L.; Cheng, S.; Kitazono, S.; Thiagarajan, M.; Goldman, J. W.; Sabari, J. K.; Sanborn, R. E.; Mansfield, A. S.; Hung, J-Y.; Popat, S.; Dias, J.; Bhattacharya, A.; Agrawal, T.; Shreeve, M.; Knoblauch, R. E.; Zhou, C. 分享 收藏
Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer Fang, Qiyu; Wan, Xiaoying; D'Aiello, Angelica; Sun, Hui; Gu, Weiquing; Li, Yixue; Zhou, Caicun; Xie, Boxiong; Deng, Qinfang; Cheng, Haiying; Zhou, Songwen 分享 收藏
分享 收藏
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China Tu, Hai-Yan; Feng, Jifeng; Shi, Meiqi; Zhao, Jun; Wang, Yuyan; Chang, Jianhua; Wang, Jialei; Cheng, Ying; Zhu, Jing; Tan, Eng-Huat; Li, Kai; Zhang, Yiping; Lee, Victor; Yang, Cheng-Ta; Su, Wu-Chou; Lam, David Chi-Leung; Srinivasa, B. J.; Rajappa, Senthil; Ho, Ching-Liang; Lam, Kwok Chi; Hu, Yi; Bondarde, Shailesh Arjun; Liu, Xiaoqing; Tian, Yahui; Xue, Zhiyi; Cseh, Agnieszka; Huang, Dennis Chin-Lun; Zhou, Caicun; Wu, Yi-Long 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations Yang, Shuo; Wang, Yan; Zhao, Chao; Li, Xuefei; Liu, Qian; Mao, Shiqi; Liu, Yiwei; Yu, Xiaofei; Wang, Wanying; Tian, Qinrun; Pan, Yingying; Xiong, Anwen; Chen, Bin; Gao, Guanghui; Li, Wei; He, Yayi; Wu, Fengying; Chen, Xiaoxia; Su, Chunxia; Ren, Shengxiang; Zhou, Caicun 分享 收藏
GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an antiPDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC) Zhou, C.; Wang, Z.; Sun, Y.; Cao, L.; Ma, Z.; Wu, R.; Yu, Y.; Yao, W.; Chang, J.; Chen, J.; Zhuang, W.; Cui, J.; Chen, X.; Lu, Y.; Shen, H.; Li, P.; Wang, J.; Sun, B.; Lu, D.; Yang, J. 分享 收藏
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients withEGFR-mutated,MET-amplified advanced non-small-cell lung cancer Yang, Jin-Ji; Fang, Jian; Shu, Yong-Qian; Chang, Jian-Hua; Chen, Gong-Yan; He, Jian Xing; Li, Wei; Liu, Xiao-Qing; Yang, Nong; Zhou, Caicun; Huang, Jian An; Frigault, Melanie M.; Hartmaier, Ryan; Ahmed, Ghada F.; Egile, Coumaran; Morgan, Shethah; Verheijen, Remy B.; Mellemgaard, Anders; Yang, Liu; Wu, Yi-Long 分享 收藏
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations 可溶性PD-L1预测EGFR突变的非小细胞肺癌患者对egfr-tki的反应 Jia, Yijun; Li, Xuefei; Zhao, Chao; Ren, Shengxiang; Su, Chunxia; Gao, Guanghui; Li, Wei; Zhou, Fei; Li, Jiayu; Zhou, Caicun 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
